NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE:FMC) on behalf of long-term stockholders following a class action complaint that was filed against FMC on May 29, 2025 with a Class Period from November 16, 2023 to February 4, 2025. Our investigation concerns whether the board of directors of FMC have breached their fiduciary duties to the company. De ...

– Data from ATH434-201 double-blind Phase 2 trial to be featured in oral session and multiple poster presentations – MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) will be ...

– Data from ATH434-201 double-blind Phase 2 trial to be featured in oral session and multiple poster presentations – MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced  that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) will b ...

ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adults Oral ANAVEX®3-71 tablet exhibits superior pharmacokinetics compared to the current immediate-release oral capsule, enabling once-daily dosing NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, sc ...

MONACO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (the “Company”) (NYSE: CMRE), an international owner and provider of containerships for charter, announced the election of two Class III directors at the Company’s virtual annual meeting of stockholders held today. The elected Class III directors are Konstantinos Konstantakopoulos and Charlotte Stratos who were elected to hold office for a term ending at the annual meeting of stockholders in 2028 and until their successors have been duly elected and q ...

SEATTLE, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) -- TappAlpha, a fintech-powered ETF issuer focused on making advanced investing strategies accessible, today announced that its flagship fund, the TappAlpha SPY Growth & Daily Income ETF (Nasdaq: TSPY), has surpassed $100 million in assets under management (AUM). Launched in August 2024, TSPY has gained rapid traction with both advisors and retail investors by offering a differentiated approach to income generation—blending core S&P 500 exposure with an active ...

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Nutex Health Inc. (NASDAQ: NUTX)?Did you purchase your shares between August 8, 2024 and August 14, ...

New and expanded AI-driven features deliver faster borrower feedback, cleaner loan files and more capacity for loan officersWILMINGTON, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced a new wave of mortgage-focused AI innovations designed to accelerate loan origination, reduce underwriting touches and deliver more responsive borrower journeys. These advances build on the Company’s spring release of Mort ...

WASHINGTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the third quarter ended September 30, 2025 before the New York market opens on Thursday, October 23, 2025. A conference call will be held to discuss these financial results on Thursday, October 23, 2025, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by logging onto the Comp ...

ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsychiatric disorders, today announced positive topline res ...